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Faculty of Medicine, Chulalongkorn University, Patumwan, Thailand
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Background: The prevalence of polyomavirus reactivation was
igher in immunocompromised patients than in normal popu-
ation. This study was done to investigate prevalence and the
ssociation between viruria of ﬁve polyomaviruses (BK, JC, WU, KI
nd TSPyV) and clinical manifestations of pediatric patients with
ystemic lupus erythematosus (SLE) on long-term immunosup-
ressants.
Methods: Pediatric patients (younger than 21 years of age)with
he diagnosis of SLE were recruited. Clinical characteristics of the
atients were obtained from medical record review. Blood were
valuated for platelet counts, hemoglobin, anti-double stranded
ds) DNA antibody and creatinine levels. Glomerular ﬁltration rate
GFR)was calculated byusing serumcreatinine. Urine proﬁleswere
ssessed by urinalysis. DNA was extracted from centrifuged urine
nd polyomavirus DNA was ampliﬁed by using speciﬁc primers
or BK, JC, WU, KI and TSPyV. Urine transforming growth factor
TGF)-1 levels were measured by ELISA. Urine specimens from 30
ealthy children were used as controls.
Results: Fifty patients (9 males and 41 females) with the mean
ge of 13±2.8 years (range 4-21 years) were included in the study.
richodysplasia spinulosa was not observed in any patients. Poly-
mavirus was identiﬁed in urine specimens from 24 patients. BK
iruria was found in 16 patients (32%) whereas JC was found in
patients (16%). WU, KI and TSPyV were not isolated from urine
pecimens of any patients. Only single viruswas isolated from each
rine specimen. Therewas no signiﬁcant difference among the age,
ype of immunosuppressants, hemoglobin levels, platelet counts,
FR and urinary proﬁles of patients with BK viruria, JC viruria and
ithout viruria. Urine TGF- 1 levels was not signiﬁcantly differ-
nt between patients with polyomaviruria and controls. Remission
f SLE (deﬁned by negative anti-ds DNA antibody) was found in a
igher rate in patients with JC viruria compared with patients with
K viruria or without viruria (P<0.03).
Conclusion:Theprevalenceof BKviruriawashigher inpediatric
atients with SLE on long term immunosuppressants. The clinical
igniﬁcance of BK viruria in this group of patients has yet to be
etermined. Minimization of immunosuppressants and close clin-
cal monitoring are extremely crucial to prevent BK nephropathy.
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Evolutionary dynamics of WNV in North America after 2006:
differential analysis of the phylogeny and selection pressure in
humans, bird, and mosquito hosts
G. Anez, A. Grinev, M. Rios ∗
FDA, Bethesda, MD, USA
Background: West Nile virus (WNV) is a mosquito-borne virus
that is maintained in a bird-mosquito enzootic cycle, but it can also
infect other vertebrates including humans. Most human infections
(∼80%) are asymptomatic, and symptomatic infections vary from
mild ﬂu-like illness (∼20%) to fatal neuroinvasive disease (∼1%).
Phylogenetic analyses have revealed two major genetic lineages of
virus, I and II but new lineages (III-V) have been recently identiﬁed.
All strains isolated from the US belong to Clade 1a of lineage I. In
2001, a newgenotype (WN02) appeared in theUS ﬁnally displacing
the ancestral genotype NY99 in 2003. The WN02 genotype became
dominant in theUS due to its ability to disseminatemore efﬁciently
in domestic mosquitoes as compared to the ancestral NY99 geno-
type. In this study we performed evolutionary dynamic analysis of
isolates circulating in the US since 2006.
Methods: We examined the genetic variation in selected WNV
strains obtained from blood donors during the US epidemic sea-
sons from 2006-2011. The study also included all other bird and
mosquito-origin ORF (open-reading frame) sequences available in
the GenBank database (1999-2009). We performed phylogenetic
analysis using maximum-likelihood and Bayesian approaches and
selection pressure analysis using HyPhy.
Results: Phylogenetic analysis conﬁrmed the presence of two
main WNV genotypes; NY99 and WN02, and the latter can be
sub-divided into three groups (g1, g2 and g3). A new sub-type
within g3 started to emerge around 2003 in Southwestern US
(SW/WN03), and within this sub-type we identiﬁed a cluster con-
stituted by strains derived fromblood donors and birds from ID and
ND detected during 2006-2007 (NW/WN06). Few nucleotide and
amino acid changes are responsible for the emergence of new US
sub-types. We detected a number of codons subjected to positive
pressure in the structural and non-structural protein genes.
Conclusion: Viral adaptation through ﬁxation of spontaneous
mutations is an important factor potentially associated with reoc-
currence of WNV outbreaks in the New World. The emergence of
new genetic variants of WNV raise issues of public health impor-http://dx.doi.org/10.1016/j.ijid.2012.05.245
